These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31774334)

  • 21. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
    Miotto P; Piana F; Migliori GB; Cirillo DM
    New Microbiol; 2008 Jan; 31(1):147-50. PubMed ID: 18437855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
    Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
    Ajbani K; Lin SY; Rodrigues C; Nguyen D; Arroyo F; Kaping J; Jackson L; Garfein RS; Catanzaro D; Eisenach K; Victor TC; Crudu V; Gler MT; Ismail N; Desmond E; Catanzaro A; Rodwell TC
    Antimicrob Agents Chemother; 2015 Jan; 59(1):414-20. PubMed ID: 25367911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance.
    Veziris N; Martin C; Brossier F; Bonnaud F; Denis F; Aubry A
    Eur J Clin Microbiol Infect Dis; 2007 Jun; 26(6):423-5. PubMed ID: 17458568
    [No Abstract]   [Full Text] [Related]  

  • 29. Real-time PCR followed by high-resolution melting curve analysis: A rapid and pragmatic approach for screening of multidrug-resistant extrapulmonary tuberculosis.
    Sharma K; Sharma M; Singh S; Modi M; Sharma A; Ray P; Varma S
    Tuberculosis (Edinb); 2017 Sep; 106():56-61. PubMed ID: 28802406
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Leechawengwongs M; Prammananan T; Jaitrong S; Billamas P; Makhao N; Thamnongdee N; Thanormchat A; Phurattanakornkul A; Rattanarangsee S; Ratanajaraya C; Disratthakit A; Chaiprasert A
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
    Zenteno-Cuevas R; Xochihua-Gonzalez O; Cuevas-Córdoba B; Victoria-Cota NL; Muñiz-Salazar R; Montero H; Hamsho-Díaz P; Lauzardo M
    Int J Antimicrob Agents; 2015 Jun; 45(6):671-3. PubMed ID: 25819011
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
    Hillemann D; Haasis C; Andres S; Behn T; Kranzer K
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29593055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Swe TL; Lwin T; Htwe MM; Kim KJ; Lee JS; Kim CK; Cho SN; Song SD; Chang CL
    Ann Lab Med; 2015 Sep; 35(5):494-9. PubMed ID: 26206685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand.
    Boonaiam S; Chaiprasert A; Prammananan T; Leechawengwongs M
    Clin Microbiol Infect; 2010 Apr; 16(4):396-9. PubMed ID: 19486070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure.
    den Hertog AL; Menting S; van Soolingen D; Anthony RM
    Emerg Infect Dis; 2014 Nov; 20(11):1932-3. PubMed ID: 25340553
    [No Abstract]   [Full Text] [Related]  

  • 37. Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
    Aye KS; Nakajima C; Yamaguchi T; Win MM; Shwe MM; Win AA; Lwin T; Nyunt WW; Ti T; Suzuki Y
    J Infect Chemother; 2016 Mar; 22(3):174-9. PubMed ID: 26806152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing.
    Colman RE; Schupp JM; Hicks ND; Smith DE; Buchhagen JL; Valafar F; Crudu V; Romancenco E; Noroc E; Jackson L; Catanzaro DG; Rodwell TC; Catanzaro A; Keim P; Engelthaler DM
    PLoS One; 2015; 10(5):e0126626. PubMed ID: 25970423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
    Mokrousov I; Otten T; Manicheva O; Potapova Y; Vishnevsky B; Narvskaya O; Rastogi N
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2937-9. PubMed ID: 18559646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
    Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
    Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.